Bruker Launches timsMRMS System, Advances Proteomics and Metabolomics Technologies
Event summary
- Bruker launched the timsMRMS system, combining trapped ion mobility separation with ultra-high-resolution magnetic resonance mass spectrometry.
- The company announced advancements in 4D proteomics, enabling the identification of over 10,000 proteins per sample and 6,500 proteins at 500 samples per day.
- Bruker introduced the timsOmni system with a new Argon option, enhancing collision-induced dissociation sensitivity by 4x for biomolecules.
- The company partnered with Integrated Protein Technologies to integrate SampleStream with timsOmni for automated, high-throughput sample preparation.
- Bruker unveiled AI-driven software innovations, including OmniScape 2027, ProteoScape 2027, and GlycoScape 2027, for improved proteoform and PTM analysis.
The big picture
Bruker's advancements in proteomics and metabolomics technologies position the company at the forefront of post-genomic research. The integration of AI-driven software and high-throughput sample preparation solutions underscores Bruker's commitment to enabling deeper insights into disease biology. These innovations are poised to accelerate drug discovery and improve the success rates of drug candidates in humans, addressing a critical need in the biopharmaceutical industry.
What we're watching
- Technology Adoption
- How the timsMRMS system will be adopted in diverse applications, from oncology research to energy industry.
- Partnership Impact
- Whether the partnership with Integrated Protein Technologies will accelerate the adoption of high-throughput proteomics workflows.
- AI Integration
- The pace at which AI-driven software innovations will enhance the accuracy and efficiency of proteoform analysis.
Related topics